Re-challenging myeloma patients with bortezomib: experience at a single centre

被引：0
|
作者：
Rabin, N
Penny, F
D'Sa, S
Yong, K
机构：
[1] Univ Coll, Dept Haematol, London, England
[2] UCL Hosp, Dept Haematol, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2006年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [1] Single centre experience with bortezomib second line and beyond for myeloma
    Collins, A.
    Mattishent, K.
    Sadullah, S.
    Gomez, C.
    Braithwaite, J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 49 - 49
  • [2] A single centre review of bortezomib home-administration in myeloma patients: portsmouth experience
    De Abrew, K.
    Blakemore, A. -M.
    Miller, C.
    Foster, K.
    Smith, K.
    Babb, A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 123 - 124
  • [3] Re-challenging eribulin in patients with ER+HER2-metastatic breast cancer: A single-institution experience
    Watanabe, J.
    Nakamoto, S.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 20 - 20
  • [4] REVERSIBILITY OF RENAL FAILURE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS: A SINGLE CENTRE EXPERIENCE
    Stefanikova, Z.
    Roziakova, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [5] IMPACT OF BORTEZOMIB IN THE SURVIVAL OF PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA WITH RENAL FAILURE. EXPERIENCE OF A SINGLE CENTRE
    Parrilla Agustin, Carreno
    Belen, Hernandez Ruiz M.
    Primo Carmen, Calle
    Eliana, Olazo
    Elisa, Pereira
    Luis, Piccone
    Alberto, Martinez-Calero
    Javier, Nieto
    Isabel, Ferreras
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 424 - 424
  • [6] The use of bortezomib in myeloma patients in a single centre following the implementation of NICE guidance
    Aung, S.
    Henshaw, S.
    Williams, C.
    Das-Gupta, E. P.
    Russell, N. H.
    Byrne, J. L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 17 - 17
  • [7] Re-Challenging with Anti-CD38 Monotherapy in Triple-Refractory Multiple Myeloma Patients Is a Feasible and Safe Approach
    Lund, Johan
    Alici, Evren
    Chrobok, Michael
    Gruber, Astrid
    Ahmadi, Tahamtan
    Khan, Imran
    Nahi, Hareth
    [J]. BLOOD, 2015, 126 (23)
  • [8] Bortezomib in relapsed/refractory myeloma patients: A single-center experience
    Grasso, M.
    Tavera, S.
    Bonferroni, M.
    Calvi, R.
    Rapezzi, D.
    Gallamini, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 149 - 150
  • [9] IMPACT OF BORTEZOMIB IN THE SURVIVAL OF PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA WITH RENAL FAILURE. EXPERIENCE OF A SINGLE CENTRE.
    Hernandez, B.
    Calle, C.
    Carreno, A.
    Rodriguez, M.
    Nebro, M.
    Tallon, I.
    Vanegas, R.
    [J]. HAEMATOLOGICA, 2012, 97 : 614 - 614
  • [10] Response to bortezomib in newly diagnosed multiple myeloma- a single centre experience from India
    Rajan, V.
    N, G.
    Nair, S. G.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 90 - 90
12345